Çѱ¹ÀϺ¸`01.6.11     ùÛÏРߧåöÌæî³Õô     Ùþè¬ ÎçòųëÆ®12-10
¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬¦¬

¼¼°è 1À§Á¦Ç° Áß±¹ÀÇ 16%, ÇٽɺÎÇ° ÇØ¿ÜÀÇÁ¸ ½ÉÈ­
ß¾ÚÝù»ÚÝ Æ¯ÃâÇÑ 1µî »ê¾÷µµ, µÎÅÍ¿î 1µî È帱ºµµ ¾ø´Ù>


    ¹ÝµµÃ¼ Á¤º¸Åë½Å µî IT»ê¾÷Àº ÀϺΠǰ¸ñ¿¡ ÆíÁßµÈ Á¦Ç°±¸Á¶¿Í ´ë¿ÜÀÇÁ¸Àû ±â¼ú ¶§¹®¿¡ ¸®½ºÅ©µµ Å©°í ¼öÃâ Áõ°¡ºÐ ¸¸Å­ ºÎÇ°, ±â¼ú¼öÀÔµµ ´Ã¾î³ª´Â ½ÇÁ¤

    »ê¾÷

    Á¡À¯À²

    ÁúÀû°æÀï·Â ¼öÁØ

    ¹ÝµµÃ¼

    45.0%

    ¸Þ¸ð¸® ºñÁß84%, ºñ¸Þ¸ð¸® 1.2%, ºñ¸Þ¸ð¸®±â¼ú¼öÁØ ÀüÁø±¹ÀÇ 50%, Àç·áÀÚ±Þ·ü 55%, ¹æºñÀÚ±ÞÀ² 13%

    Á¤º¸Åë½Å

    3.1%

    CDMA´Ü¸»±â ºÎÇ°±¹»êÈ­À²63%, µðÁöÅÐTV ¸ÅÃâ11%, PC´Â 12%°¡ ÇØ¿Ü ±â¼ú»ç¿ë·á

    ÀÚµ¿Â÷

    5.8%

    Ç°Áú 28~37À§ ¼öÁØ, ¿¬±¸°³¹ßºñ ¼±Áø±¹ÀÇ1/8

    ö°­

    5.1%

    ¸ÅÃâ´ëºñ R&D ÅõÀÚºñÀ² 0.6%(ÀϺ» 19%)

    Á¶¼±

    51.5%

    À¯¶÷¼± µî ºÎ°¡°¡Ä¡¼± ºñÁß 25~30%(ÀϺ» 70%)

    ¼¶À¯

    10.8%

    ÀӱݼöÁØ Áß±¹ÀÇ 149¹è

    ÀÚ·á : »ï¼º°æÁ¦¿¬±¸¼Ò